Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS093362, R01NS105971, U54NS092089, P30 NS055077)
National Institute on Aging (U01AG045390, P50AG025688, U24 AG21886)
Received: 10 September 2020
Accepted: 13 September 2020
First Online: 7 October 2020
Ethics approval and consent to participate
: All animal procedures and studies were reviewed and approved by the institutional animal care and use committee (IACUC) at Emory University. Human biological samples were obtained with Institutional Review Board approval.
: Not applicable.
: Patent pending related to this work entitled “Methods to treat neurodegeneration with granulins” to TK. The authors declare that they have no competing interests.